Actively Recruiting

Age: 18Years - 75Years
All Genders
NCT07062380

AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)

Led by Tongji Hospital · Updated on 2025-09-03

353

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This observational study aims to validate a deep learning model for predicting aggressive recurrence patterns in patients with early-stage liver cancer (HCC) after surgery. The main question it aims to answer is: Can the AI model accurately identify patients at high risk of cancer recurrence within 2 years after surgery? Participants will provide clinical data and undergo standard surgery, followed by 2-year imaging surveillance. Their data will be used for both AI prediction and validation of recurrence patterns.

CONDITIONS

Official Title

AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18-75 years, regardless of gender.
  • Diagnosed with BCLC stage 0-A hepatocellular carcinoma and scheduled for curative liver resection.
  • Preoperative clinical diagnosis of hepatocellular carcinoma (HCC).
  • Have a dynamic contrast-enhanced MRI within 1 month before surgery with acceptable image quality.
  • Child-Pugh liver function score of 7 or less.
  • ECOG Performance Status of 0 or 1.
  • No severe organic diseases affecting heart, lungs, brain, or other vital organs.
Not Eligible

You will not qualify if you...

  • Having other active malignancies except cured non-melanoma skin cancer or cervical carcinoma in situ.
  • Postoperative pathology shows diagnosis other than hepatocellular carcinoma.
  • Pregnant or breastfeeding women.
  • History of organ transplantation.
  • Unable to follow the study protocol or attend scheduled follow-ups.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tongji Hospital

Wuhan, Hubei, China, 430030

Actively Recruiting

Loading map...

Research Team

Y

Yang Wu, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR) | DecenTrialz